You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

estrogen receptor-positive breast cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Brain Metastases Trial in New York (Brain Imaging with 18F-FES)

Not yet recruiting
  • Breast Cancer
  • Brain Metastases
  • Brain Imaging with 18F-FES
  • New York, New York
    New York-Presbyterian/Weill Cornell Medical Center
Oct 2, 2023

Estrogen Receptor Positive Breast Cancer Trial in Edmonton (Estradiol)

Active, not recruiting
  • Estrogen Receptor Positive Breast Cancer
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Feb 1, 2023

Estrogen Receptor Positive Breast Cancer, Breast Cancer Trial in Houston (ESTRING, Replens)

Recruiting
  • Estrogen Receptor Positive Breast Cancer
  • Breast Cancer
  • Houston, Texas
    Houston Methodist Cancer Center
Nov 18, 2022

Estrogen-receptor-positive Breast Cancer, HER2/Neu-Negative Breast Cancer, Advanced Breast Cancerv Trial in Chicago

Not yet recruiting
  • Estrogen-receptor-positive Breast Cancer
  • +3 more
  • elacestrant, palbociclib, abemaciclib, ribociclib
  • Chicago, Illinois
    Northwestern University
Sep 25, 2023

Early-stage Breast Cancer, Estrogen-receptor-positive Breast Cancer Trial in Brussels (Prospective data and sample collection,

Not yet recruiting
  • Early-stage Breast Cancer
  • Estrogen-receptor-positive Breast Cancer
  • Prospective data and sample collection
  • +2 more
  • Brussels, Belgium
    Imane Bachir
Nov 27, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8 Trial in San Francisco (Pembrolizumab,

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Prognostic Stage IV Breast Cancer AJCC v8
  • Pembrolizumab
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Jan 5, 2023

Electronic Medical Record-Based Nudge to Reduce SLNB

Recruiting
  • Breast Cancer
  • Estrogen-receptor-positive Breast Cancer
  • Column-based nudge in the EHR
  • No column-based nudge in the EHR
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Aug 17, 2023

Breast Cancer Trial in United States (Avelumab, Endocrine therapy, Palbociclib)

Recruiting
  • Breast Cancer
  • Birmingham, Alabama
  • +3 more
Apr 15, 2022

Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma Trial in Boston,

Active, not recruiting
  • Estrogen Receptor-positive Breast Cancer
  • +5 more
  • PI3K inhibitor BYL719
  • +3 more
  • Boston, Massachusetts
  • +1 more
Oct 14, 2022

Estrogen Receptor Positive Breast Cancer, Breast Tumor, Metastatic Breast Cancer Trial in Philadelphia ([18F]FES)

Active, not recruiting
  • Estrogen Receptor Positive Breast Cancer
  • +2 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania Hospital
Jul 5, 2022

FDG PET/CT in Breast Cancer Bone Mets

Active, not recruiting
  • Estrogen Receptor Positive Breast Cancer
  • Bone Metastases
  • FDG PET/CT scan
  • Philadelphia, Pennsylvania
    University of Pennsylvania Hospital
Oct 13, 2022

Metastatic Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7 Trial in United States (drug, other, biological)

Suspended
  • Metastatic Breast Carcinoma
  • Stage IV Breast Cancer AJCC v6 and v7
  • Corona, California
  • +6 more
Sep 28, 2022

Breast Tumors, Invasive Breast Cancer, Estrogen-receptor-positive Breast Cancer Trial in United States (Z-endoxifen, exemestane,

Recruiting
  • Breast Neoplasms
  • +3 more
  • Phoenix, Arizona
  • +3 more
Jan 30, 2023

Breast Cancer Trial in Sarasota, Nashville (AC699)

Recruiting
  • Breast Cancer
  • Sarasota, Florida
  • +1 more
Jan 3, 2023

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Trial (Giredestrant, Fulvestrant, Abemaciclib)

Not yet recruiting
  • Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
  • (no location specified)
Sep 26, 2023

Estrogen Receptor-positive Breast Cancer, Musculoskeletal Complications, Progesterone Receptor-positive Breast Cancer Trial in

Active, not recruiting
  • Estrogen Receptor-positive Breast Cancer
  • +9 more
  • Boston, Massachusetts
  • +1 more
Sep 9, 2022

Breast Cancer Stage IV Trial in Irvine (Gallium-68)

Recruiting
  • Breast Cancer Stage IV
  • Irvine, California
    Hoag Memorial Hospital Presbyterian
May 26, 2023

Estrogen Receptor-positive Breast Cancer Trial in Nashville (2-Week Ketogenic Diet, Letrozole)

Recruiting
  • Estrogen Receptor-positive Breast Cancer
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Sep 20, 2022

Breast Cancer Trial in Orange City (ARV-471 (PF-07850327), Palbociclib, Letrozole)

Recruiting
  • Breast Cancer
  • ARV-471 (PF-07850327)
  • +2 more
  • Orange City, Florida
    Mid Florida Hematology and Oncology Center
Jun 8, 2023

Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

Recruiting
  • Hormone Receptor Positive HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jun 12, 2023

Breast Tumors Trial in Chuo Ku, Koto-Ku (H3B-6545, Antihistamine)

Active, not recruiting
  • Breast Neoplasms
  • Chuo Ku, Japan
  • +1 more
Dec 19, 2022

Breast Cancer, Estrogen Receptor-positive Breast Cancer Trial in Charlottesville (Aspirin, Tamoxifen Pill, Doxorubicin)

Withdrawn
  • Breast Cancer
  • Estrogen Receptor-positive Breast Cancer
  • Charlottesville, Virginia
    University of Virginia
Nov 12, 2021

Breast Cancer Trial in Beijing, Zhengzhou, Changsha (EG017)

Not yet recruiting
  • Breast Cancer
  • Beijing, Benjing, China
  • +2 more
Dec 30, 2022

Personalised Disease Monitoring in Metastatic Breast Cancer

Recruiting
  • Breast Cancer Metastatic
  • Estrogen Receptor-positive Breast Cancer
    • Gothenburg, Sweden
    • +6 more
    Dec 7, 2022

    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer Trial in

    Terminated
    Has Results
    • Estrogen Receptor-positive Breast Cancer
    • +7 more
    • Atlanta, Georgia
    • +2 more
    Mar 10, 2022